Correction published: 11 September 2017 doi: 10.3389/fped.2017.00187
Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children Edited by: Carlo Caffarelli, University of Parma, Italy Reviewed by: George N. Konstantinou, 424 Military Medical Training Hospital, Greece Elisabetta Calamelli, Università di Bologna, Italy *Correspondence: Sophia Tsabouri [email protected] Specialty section: This article was submitted to Pediatric Pulmonology, a section of the journal Frontiers in Pediatrics Received: 25 April 2017 Accepted: 15 August 2017 Published: 11 September 2017 Citation: Tsabouri S, Mavroudi A, Feketea G and Guibas GV (2017) Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children. Front. Pediatr. 5:187. doi: 10.3389/fped.2017.00187
Frontiers in Pediatrics | www.frontiersin.org
Sophia Tsabouri1*, Antigoni Mavroudi 2, Gavriela Feketea 3 and George V. Guibas 4,5 1 Child Health Department, University Hospital of Ioannina, Medical School of Ioannina, Ioannina, Greece, 2 Allergy Unit of the 3rd Pediatric Department, Aristotle University of Thessaloniki, Ioannina, Greece, 3 Amaliada Hospital Unit, General Hospital of Ilias, Amaliada, Ioannina, Greece, 4 Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom, 5 Allergy Department, University Hospitals South Manchester NHS Trust, Manchester, United Kingdom
Keywords: subcutaneous immunotherapy, sublingual immunotherapy, children, allergy, asthma
A corrigendum on Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children by Tsabouri S, Mavroudi A, Feketea G, Guibas GV. Front Pediatr (2017) 5:82. doi: 10.3389/fped.2017.00082 In the original article [Contraindications], paragraph 6, line 159, there was an error. The phrase “Furthermore, well-controlled asthma, regardless of its severity, is not a contradiction for AIT,” was contradicting other assertions in the “contraindications” paragraph. The following sentence should be disregarded: [Furthermore, well-controlled asthma, regardless of its severity, is not a contradiction for AIT (36).] The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Copyright © 2017 Tsabouri, Mavroudi, Feketea and Guibas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
1
September 2017 | Volume 5 | Article 187
Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children Edited by: Carlo Caffarelli, University of Parma, Italy Reviewed by: George N. Konstantinou, 424 Military Medical Training Hospital, Greece Elisabetta Calamelli, Università di Bologna, Italy *Correspondence: Sophia Tsabouri [email protected] Specialty section: This article was submitted to Pediatric Pulmonology, a section of the journal Frontiers in Pediatrics Received: 25 April 2017 Accepted: 15 August 2017 Published: 11 September 2017 Citation: Tsabouri S, Mavroudi A, Feketea G and Guibas GV (2017) Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children. Front. Pediatr. 5:187. doi: 10.3389/fped.2017.00187
Frontiers in Pediatrics | www.frontiersin.org
Sophia Tsabouri1*, Antigoni Mavroudi 2, Gavriela Feketea 3 and George V. Guibas 4,5 1 Child Health Department, University Hospital of Ioannina, Medical School of Ioannina, Ioannina, Greece, 2 Allergy Unit of the 3rd Pediatric Department, Aristotle University of Thessaloniki, Ioannina, Greece, 3 Amaliada Hospital Unit, General Hospital of Ilias, Amaliada, Ioannina, Greece, 4 Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom, 5 Allergy Department, University Hospitals South Manchester NHS Trust, Manchester, United Kingdom
Keywords: subcutaneous immunotherapy, sublingual immunotherapy, children, allergy, asthma
A corrigendum on Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children by Tsabouri S, Mavroudi A, Feketea G, Guibas GV. Front Pediatr (2017) 5:82. doi: 10.3389/fped.2017.00082 In the original article [Contraindications], paragraph 6, line 159, there was an error. The phrase “Furthermore, well-controlled asthma, regardless of its severity, is not a contradiction for AIT,” was contradicting other assertions in the “contraindications” paragraph. The following sentence should be disregarded: [Furthermore, well-controlled asthma, regardless of its severity, is not a contradiction for AIT (36).] The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Copyright © 2017 Tsabouri, Mavroudi, Feketea and Guibas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
1
September 2017 | Volume 5 | Article 187
